latestage

  1. T

    Kadcyla For Late-Stage Breast Cancer Approved By FDA

    Kadcyla (ado-trastuzumab emtansine), a new medication for the treatment of HER2-positive, metastatic breast cancer, has been approved by the Food and Drug Administration (FDA), USA. Metastatic, also known as late-stage, means the cancer has spread to other parts of the body. HER2, a protein...
  2. T

    Enzalutamide Adds 5 Months Survival In Late-Stage Prostate Cancer

    Results of a phase III clinical trial of the drug Enzalutamide, published recently in the New England Journal of Medicine, show the drug extends life by an average five months in the most advanced stages of prostate cancer. "This is a major advance. Not only do we see more survival benefit than...
    • tD33NAt
    • Thread
    • adds cancer enzalutamide latestage months prostate survival
    • Replies: 0
    • Forum: Health and Fitness
  3. T

    Adding Ipilimumab To Standard Chemotherapy Treatment For Late-Stage Lung Cancer May I

    Ipilimumab used in combination with paclitaxel/carboplatin for stage IIIb/IV non-small cell lung cancer showed superior results in progression free survival when compared to paclitaxel/carboplatin alone, according to research presented at the 2010 Chicago Multidisciplinary Symposium in Thoracic...
    • tD33NAt
    • Thread
    • adding cancer chemotherapy ipilimumab latestage lung standard treatment
    • Replies: 0
    • Forum: Health and Fitness
  4. T

    Biogen Idec And Knopp Neurosciences Announce License Agreement For Late-Stage ALS Dru

    Biogen Idec (NASDAQ: BIIB) and Knopp Neurosciences announced they have entered into an exclusive, worldwide license agreement under which Biogen Idec will develop and commercialize KNS-760704 (dexpramipexole) for the treatment of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's...
    • tD33NAt
    • Thread
    • agreement als announce biogen dru idec knopp latestage license neurosciences
    • Replies: 0
    • Forum: Health and Fitness
Top